![Adicet Bio, Inc. logo](/logos/ACET.webp)
Adicet Bio, Inc.
NASDAQ:ACET
Overview | Financials
Company Name | Adicet Bio, Inc. |
Symbol | ACET |
Currency | USD |
Price | 1.48 |
Market Cap | 121,953,480 |
Dividend Yield | 0% |
52-week-range | 1.05 - 3.77 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Chen Schor BA, CPA, CPA, M.B.A., MBA |
Website | https://www.adicetbio.com |
An error occurred while fetching data.
About Adicet Bio, Inc.
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD